ASX - By Stock
|
NOX |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
19661966
|
5 |
1.0K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
5
|
1.0K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
19661966
|
5 |
1.0K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
5
|
1.0K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
35
|
14K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
35
|
14K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
35
|
14K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
35
|
14K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
35
|
14K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Appendix 4D and Half Year 2024 Financial Report
|
|
19661966
|
35 |
14K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
35
|
14K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm extends Hudson Institute strategic partnership
|
|
19661966
|
3 |
1.7K |
1 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
3
|
1.7K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm extends Hudson Institute strategic partnership
|
|
19661966
|
3 |
1.7K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
3
|
1.7K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: December 2023 Quarterly Activities Report and Appendix 4C
|
|
19661966
|
2 |
1.2K |
3 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
2
|
1.2K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
19661966
|
11 |
6.8K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
19661966
|
11 |
6.8K |
1 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
19661966
|
11 |
6.8K |
1 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
19661966
|
11 |
6.8K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
19661966
|
11 |
6.8K |
1 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
the next Disallowed
|
|
19661966
|
11 |
6.8K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
11
|
6.8K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
45
|
18K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Results of Meeting
|
|
19661966
|
2 |
1.1K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
0 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
45
|
18K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
45
|
18K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
18K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
18K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
18K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
18K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
1 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
18K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
45
|
18K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
45
|
18K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
4 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
45
|
18K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
4 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
45
|
18K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
45
|
18K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
LUPIN again
|
|
19661966
|
5 |
1.9K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
5
|
1.9K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction
|
|
19661966
|
45 |
18K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
45
|
18K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: US FDA grants Orphan Drug Designation for CRO-67
|
|
19661966
|
64 |
28K |
1 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
64
|
28K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: September 2023 Activities Report and Appendix 4C
|
|
19661966
|
7 |
2.4K |
0 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
7
|
2.4K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: US FDA grants Orphan Drug Designation for CRO-67
|
|
19661966
|
64 |
28K |
0 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
64
|
28K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: US FDA grants Orphan Drug Designation for CRO-67
|
|
19661966
|
64 |
28K |
4 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
64
|
28K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: US FDA grants Orphan Drug Designation for CRO-67
|
|
19661966
|
64 |
28K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
64
|
28K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: US FDA grants Orphan Drug Designation for CRO-67
|
|
19661966
|
64 |
28K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
64
|
28K
|
1
|
|